For results that have...

But don't include...

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease
Overview
The American Diabetes Association has developed education materials for clinicians, patients and caregivers to help them better understand the issues related to therapy with antipsychotic drugs in patients who may have diabetes and/or cardiovascular disease risk factors. The objective of these tools is to assist in establishing the relationship between antipsychotic medications and diabetes, obesity, and cardiovascular disease.
 
** These resources are one part of a larger CME initiative entitled "Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease”, which was implemented in 2005.
 
Target Audience:
The professional education materials are targeted to psychiatrists, as well as primary care providers, nurse practitioners, nurses, and other interested health professionals who treat patients with psychiatric illness.
 
The patient education materials are targeted towards patients with a diagnosed psychiatric disorder and/or have been diagnosed with pre-diabetes or diabetes.
 
Commercial Support
This activity is supported by an unrestricted educational grant from Bristol-Myers Squibb.
 
**The American Diabetes Association would like to thank Dr. John Newcomer and Karen Flavin, RN, CCRC for their hard work and dedication in development of these tools, and offer thanks as well as for the contributions of Drs John Devlin, Patrick Lustman, James Levine and Gail Daumit.
 


Professional Tools
 
 
 
 
 


Additional Literature Resources for Professionals
 
 
 


Patient Tools
 
 
 
 
 
Additional patient education materials available in both English and Spanish (Coming Soon)